J2995 HCPCS code: Injection, streptokinase, per 250,000 iu
J2995 is the HCPCS Level II code for injection, streptokinase, per 250,000 iu. CMS terminated J2995 on 2025-12-31; do not bill it for later dates of service. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1986-01-01 |
| Last action effective | 2026-01-01 |
| Terminated | 2025-12-31 |
What changed for J2995
- 1986-01-01: J2995 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2995?
J2995 is the HCPCS Level II code for injection, streptokinase, per 250,000 iu. Short descriptor: "Inj streptokinase /250000 iu".
Does Medicare cover J2995?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Related J29 codes
- J2910 — Injection, aurothioglucose, up to 50 mg
- J2916 — Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
- J2919 — Injection, methylprednisolone sodium succinate, 5 mg
- J2920 — Injection, methylprednisolone sodium succinate, up to 40 mg
- J2930 — Injection, methylprednisolone sodium succinate, up to 125 mg
- J2940 — Injection, somatrem, 1 mg
- J2941 — Injection, somatropin, 1 mg
- J2950 — Injection, promazine hcl, up to 25 mg
- J2993 — Injection, reteplase, 18.1 mg
- J2997 — Injection, alteplase recombinant, 1 mg
- J2998 — Injection, plasminogen, human-tvmh, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2995
- Watch J2995 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2995
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.